Virtu KCG Holdings’s Interpace Biosciences, Inc. Common Stock IDXG Stock Holding History

Virtu KCG Holdings’s Portfolio IDXG Stock Details IDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$66K	Buy	+7,372	New	+$144K	﹤0.01%	2528
2017 Q1	–	Sell	-4,045	Closed	-$108K	–	4014
2016 Q4	$108K	Buy	4,045 +1,241	+44%	+$39.6K	﹤0.01%	2888
2016 Q3	$45K	Buy	+2,804	New	+$77.5K	﹤0.01%	2809
2016 Q2	–	Sell	-104	Closed	-$3K	–	3496
2016 Q1	$3K	Buy	+104	New	+$2.78K	﹤0.01%	2694
2015 Q3	–	Sell	-121	Closed	-$17K	–	4021
2015 Q2	$17K	Buy	+121	New	+$16.8K	﹤0.01%	3202
2015 Q1	–	Sell	-101	Closed	-$18K	–	4151
2014 Q4	$18K	Buy	+101	New	+$18K	﹤0.01%	3612

Other funds holding IDXG

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Virtu KCG Holdings's IDXG Position: Q2 2017 in Review

Virtu KCG Holdings opened a new position in Interpace Biosciences, Inc. Common Stock (IDXG) in Q2 2017: 7,372 shares worth $66K. The stake represents ﹤0.01% of the portfolio and ranks #2528 among its holdings. This is a return to the name: Virtu KCG Holdings previously reported a position in IDXG as recently as Q4 2016.

Virtu KCG Holdings first reported a position in IDXG in Q4 2014 and has held it in 6 quarters since. The position peaked at $108K in Q4 2016. 17 funds tracked by Wall St. Rank hold IDXG as of Q2 2017.

Virtu KCG Holdings held 7,372 shares of Interpace Biosciences, Inc. Common Stock worth $66K as of Q2 2017.
Interpace Biosciences, Inc. Common Stock was a new Virtu KCG Holdings position in Q2 2017.
Interpace Biosciences, Inc. Common Stock made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2528 holding.
Virtu KCG Holdings first reported a position in Interpace Biosciences, Inc. Common Stock in Q4 2014 and has held it in 6 quarters since.
Virtu KCG Holdings's Interpace Biosciences, Inc. Common Stock position peaked at $108K in Q4 2016.
17 funds tracked by Wall St. Rank held Interpace Biosciences, Inc. Common Stock as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.